Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,678.5
25.5 (0.96%)

 

  • STI Straits Times Index
    2,678.5
    25.5 (0.96%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,571.6
    18.9 (1.22%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,248.2
    875.1 (3.45%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,286.6
    133.8 (4.24%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,685.9
    379.5 (1.70%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,995.2
    21.5 (0.43%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 697.1M
  • Value: 416.4M
  • Rise: 211
  • Fall: 73
  • Unch: 524

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Singapore-eDev0.121+0.006
Medtecs Intl0.580+0.080
Rex Intl0.184+0.004
LionGold0.002-
Synagie0.198+0.007
Yoma Strategic0.320+0.005
MDR0.001-
AnAn Intl0.070+0.006
Spackman0.009-0.001
Adventus0.023+0.002

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,265.5 -284.5
HSCEI 9,743.2 -110.0
Jakarta 4,863.1 -41.0
Nikkei 225 22,047.8 -464.2
SSE Comp 2,960.5 -10.1
Shanghai A 3,103.1 -10.6
Shanghai B 211.8 -1.7
KOSPI 2,097.3 -37.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

YESTAR HEALTH YESTAR HEALTH
Quotes 15 Minutes Delayed. Updated at 06 Jul 2020 11:59
Last (HKD): 1.230 Change: +0.030 High: 1.270 Remarks: -
Change (%): +2.50 Low: 1.190
Open 1.220 Yesterday's Close 1.200
Buy Price 1.220 Sell Price 1.230
Buy Volume ('000) 10 Sell Volume ('000) 5
Cumulative Volume ('000) 1,145 Cumulative Value 1,416,875
Click to show Stock Prices chart

Key Statistics

EPS (HKD) a 0.09754 Trailing EPS (HKD) e 0.09754 NAV (HKD) b 0.5567
PE a 12.610 Trailing PE f 12.611 Price / NAV b 2.2094
Dividend (HKD) d - Cash In Hand (HKD) g 0.3157 Issued & Paid-up Shares c 2,356,162,500
Dividend Yield (%) d - Price / Cash In Hand g 3.896 Treasury Shares h 3,427,500
Beta - 75 Daysi 0.185 R-Squared - 75 Days(%)i 2.44 Market Cap (M) 2,898.080
Beta - 500 Daysi 0.140 R-Squared - 500 Days (%)i 0.53 Enterprise Value (M) 4,367.227
Piotroski F Score 6 Exchange Code 2393 Par Value ( HKD ) 0.02500
52 Weeks Volatility (%) 47.33 6-Month VWAP 1.401 Free Float (%) 29.6
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 03 Jul 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 21 Apr 2020.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference YESTAR HEALTH HKEx 2,898.080 12.610 12.611 2.2094 -
Industry Medical Specialties HKEx 17,397.612 110.636 110.636 6.6747 0.292
Local Peer WEIGAO GROUP HKEx 83,301.319 39.820 39.820 4.6011 0.720
Local Peer MICROPORT HKEx 62,006.344 170.991 170.995 15.3325 0.139
Local Peer KANGJI MEDICAL HKEx 37,065.416 179.546 179.542 113.2798 -
Local Peer VENUS MEDTECH-B HKEx 33,166.450 - - 9.7631 -
Local Peer AK MEDICAL HKEx 29,018.918 95.853 95.852 23.2465 0.272
Local Peer PEIJIA-B HKEx 21,550.858 - - -38.6054 -
Local Peer KDL MEDICAL HKEx 11,678.100 103.387 103.388 8.5828 0.277
Local Peer LIFETECH SCI HKEx 9,625.296 65.699 65.701 7.4697 -
Local Peer CIRC HKEx 7,213.177 19.333 19.333 1.7153 0.677
Local Peer PW MEDTECH HKEx 2,589.262 27.853 27.853 0.5023 -
Local Peer GOLDEN MEDITECH HKEx 2,333.544 - - 0.6069 -
Local Peer MODERN DENTAL HKEx 1,383.946 8.566 8.566 0.6848 3.704
Other Local Peers VINCENT MED (HKEx), YUNNAN ENERGY (HKEx), KELFRED (HKEx), LIFE HEALTHCARE (HKEx), HUAKANG BIOMED (HKEx)
Global Peer ABBOTT LABORATORIES NYSE 163,141.035 44.501 46.098 5.3988 1.426
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 144,508.621 39.099 39.386 5.0600 0.210
Global Peer DANAHER CORP NYSE 127,293.757 51.147 46.508 4.3216 0.372
Global Peer MEDTRONIC PLC NYSE 124,955.508 26.092 26.092 2.4628 2.318
Global Peer BECTON DICKINSON & CO NYSE 69,460.859 64.197 76.331 3.3157 1.199
Global Peer STRYKER CORP NYSE 68,945.862 33.099 31.860 5.2570 1.160
Global Peer INTUITIVE SURGICAL INC NASDAQ 67,694.417 49.079 48.831 7.9578 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 50,548.467 10.755 11.791 3.6619 -
Global Peer BAXTER INTERNATIONAL INC NYSE 44,375.588 44.331 43.463 5.7638 0.970
Global Peer EDWARDS LIFESCIENCES CORP NYSE 42,874.552 40.954 38.702 10.9904 -
Other Global Peers KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 (NYSE), DEXCOM INC (NASDAQ), ALCON AG (NYSE), IDEXX LABORATORIES INC (NASDAQ), RESMED INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), ALIGN TECHNOLOGY INC (NASDAQ), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), METTLER-TOLEDO INTERNATIONAL INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), TELEFLEX INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), COOPER COS INC (NYSE), HOLOGIC INC (NASDAQ), BIO RAD LABORATORIES INC (NYSE), INSULET CORPORATION (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), STERIS PLC (NYSE), HARTA (Bursa), MASIMO CORPORATION (NASDAQ), ABIOMED INC (NASDAQ), TOPGLOV (Bursa), Top Glove (SGX), WATERS CORP (NYSE), VARIAN MEDICAL SYSTEMS INC (NYSE), PERKINELMER INC (NYSE), QIAGEN NV (NYSE), DENTSPLY SIRONA INC (NASDAQ), QUIDEL CORP (NASDAQ), COCHLEAR LTD (ASX), HILL-ROM HOLDINGS INC (NYSE), PENUMBRA INC (NYSE), BRUKER CORPORATION (NASDAQ), NOVOCURE LTD (NASDAQ), TANDEM DIABETES CARE INC (NASDAQ), GLOBUS MED INC (NYSE), HAEMONETICS CORP (NYSE), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), NEOGEN CORP (NASDAQ), NEVRO CORP (NYSE), ICU MEDICAL INC (NASDAQ), WRIGHT MEDICAL GROUP NV (NASDAQ), ENVISTA HOLDINGS CORPORATION (NYSE), INOVIO PHARMACEUTICALS INC (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), NUVASIVE INC (NASDAQ), SUPERMX (Bursa), STAAR SURGICAL CO (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), LIVANOVA PLC (NASDAQ), INSPIRE MEDICAL SYSTEMS INC (NYSE), INARI MEDICAL INC (NASDAQ), EBOS GROUP (ASX), CONMED CORP (NYSE), ATRICURE INC (NASDAQ), CANTEL MEDICAL CORP (NYSE), GLAUKOS CORPORATION (NYSE), CAREDX INC (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), BIOTELEMETRY INC (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), AVANOS MEDICAL INC (NYSE), NANOSONICS LIMITED (ASX), SILK ROAD MEDICAL INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), ATRION CORP (NASDAQ), CERUS CORP (NASDAQ), MESA LABORATORIES INC (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), VAPOTHERM INC (NYSE), INMODE LTD (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), HESKA CORP (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), ZYNEX INC (NASDAQ), INOGEN INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), CRYOLIFE INC (NYSE), VERICEL CORP (NASDAQ), AVITA THERAPEUTICS INC (NASDAQ), QUOTIENT LTD (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), SURMODICS INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), TRANSMEDICS GROUP INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), SI BONE INC (NASDAQ), AXOGEN INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), CORMEDIX INC (NYSE American), CYTOSORBENTS CORP (NASDAQ), VIEWRAY INC (NASDAQ), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), MCP INCOME OPPORTUNITIES TRUST (ASX), MEDICAL DEVELOPMENT INTL (ASX), ALPHATEC HLDGS INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), STEREOTAXIS INC (NYSE American), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), IRADIMED CORP (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), PROFOUND MED CORP (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), ALPHA PRO TECH (NYSE American), MISONIX INC (NASDAQ), INVACARE CORP (NYSE), RTI SURGICAL HOLDINGS INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), CUTERA INC (NASDAQ), DERMTECH INC (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), SIENTRA INC (NASDAQ), Medtecs Intl (SGX), TELA BIO INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), UG Healthcare (SGX), APYX MEDICAL CORPORATION (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), SOLITON INC (NASDAQ), FONAR CORP (NASDAQ), CELSION CORPORATION (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), ATOMO DIAGNOSTICS LIMITED (ASX), ELECTROMED INC (NYSE American), BELLEROPHON THERAPEUTICS INC (NASDAQ), INTRICOM CORP (NASDAQ), VENUS CONCEPT INC (NASDAQ), VOLITIONRX LIMITED (NYSE American), PAVMED INC (NASDAQ), BIOMERICA INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), RESAPP HEALTH LIMITED (ASX), CYCLOPHARM LIMITED (ASX), SOMNOMED LIMITED (ASX), EMVISION MEDICAL DEVICES LTD (ASX), NEPHROS INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), NOVA EYE MEDICAL LIMITED (ASX), DAXOR CORP (NYSE American), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), LKL (Bursa), Biolidics (SGX), SDI LTD (ASX), CLEARPOINT NEURO INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), CONFORMIS INC (NASDAQ), TITAN MEDICAL INC (NASDAQ), IMPEDIMED LIMITED (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), DIMERIX LTD (ASX), SENSUS HEALTHCARE INC (NASDAQ), ONCOCYTE CORP (NYSE American), COMPUMEDICS (ASX), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), RESONANCE HEALTH LTD (ASX), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), RESPIRI LTD (ASX), MOTUS GI HOLDINGS INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), IMMUCELL CORP (NASDAQ), NEOVASC INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), NEURONETICS INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), OVENTUS MEDICAL LTD (ASX), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), Yunnan Energy (SGX), MICRO-X LTD (ASX), ELECTROCORE INC (NASDAQ), LBT INNOVATIONS LTD (ASX), IRIDEX CORP (NASDAQ), IMPRESSION HEALTHCARE LIMITED (ASX), METALICITY LIMITED (ASX), NEUROTROPE INC (NASDAQ), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), USCOM LTD (ASX), DARIOHEALTH CORP (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), AKERS BIOSCIENCES INC (NASDAQ), MYOS RENS TECHNOLOGY INC (NASDAQ), BIOLASE INC (NASDAQ), CHF SOLUTIONS INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), LIANLUO SMART LIMITED (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), AETHLON MEDICAL INC (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), IMAGION BIOSYSTEMS LIMITED (ASX), PREDICTIVE ONCOLOGY INC (NASDAQ), CHECK-CAP LTD (NASDAQ), AVINGER INC (NASDAQ), RA MEDICAL SYSTEMS INC (NYSE), ENDOLOGIX INC (NASDAQ), CYANOTECH CORP (NASDAQ), OPTISCAN IMAGING (ASX), DIGIRAD CORP (NASDAQ), CARDIEX LTD (ASX), DYNATRONICS CORP (NASDAQ), Annica (SGX), ADHERIUM LIMITED (ASX), HANCOCK JAFFE LABORATORIES INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), CANCER GENETICS INC (NASDAQ), ANALYTICA (ASX), ALLEGRA ORTHOPAEDICS LIMITED (ASX), DORSAVI LTD (ASX), NEUROMETRIX INC (NASDAQ), OBALON THERAPEUTICS INC (NASDAQ), INSPIREMD INC (NYSE American), MEDIGARD LIMITED (ASX), NEUROTECH INTERNATIONAL LTD (ASX), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.040
+3.36 %
10 Days -+0.040
+3.36 %
20 Days -+0.080
+6.96 %
Medium Term Return 3 Months --0.050
-3.91 %
6 Months --0.260
-17.45 %
1 Year -+0.210
+20.59 %
Long Term Return 2 Years --1.420
-53.58 %
3 Years 0.055-2.740
-67.63 %
5 Years 0.138-1.290
-45.71 %
Annualised Return Annualised --
-11.50 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 1.000 - 2.000 Change From 1 Year Low +0.230 % Change From 1 Year Low (%) +23.00
Change From 1 Year High -0.770 % Change From 1 Year High (%) -38.50
2 Years Range 1.000 - 2.660 Change From 2 Years Low +0.230 % Change From 2 Years Low (%) +23.00
Change From 2 Years High -1.430 % Change From 2 Years High (%) -53.76
5 Years Range 1.000 - 4.600 Change From 5 Years Low +0.230 % Change From 5 Years Low (%) +23.00
Change From 5 Years High -3.370 % Change From 5 Years High (%) -73.26
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Yestar Healthcare Holdings Co. Ltd. engages in the provision of investment with interests in the manufacture, distribution, and sale of medial imaging products and other related solutions. It operates through the following segments: Imaging Printing Products; and Medical Products & Equipment. The Imaging Printing products segment refers to the manufacture and sale of color photographic paper, industrial NDT x-ray films, and PWB films, as well as the trading of imaging equipment. The Medical Products and Equipment segment relates to the manufacture and sale of medical dry films, medical wet and dental films, sale of medical equipment and diagnostic reagents. The company was founded in 2000 and is headquartered in Hong Kong.

Historical Price Data

Date Open High Low Close Volume VWAP
03 Jul 2020 1.300 1.300 1.180 1.200 327,500 1.1976
02 Jul 2020 1.270 1.270 1.180 1.190 170,000 1.2160
30 Jun 2020 1.190 1.270 1.180 1.190 712,500 1.2484
29 Jun 2020 1.180 1.190 1.170 1.190 462,500 1.1882
26 Jun 2020 1.200 1.200 1.170 1.190 647,500 1.1805
24 Jun 2020 1.210 1.220 1.190 1.190 767,500 1.1933
23 Jun 2020 1.220 1.220 1.180 1.210 207,500 1.2093
22 Jun 2020 1.200 1.200 1.190 1.190 72,500 1.1993
19 Jun 2020 1.200 1.200 1.170 1.190 1,032,500 1.1852
18 Jun 2020 1.210 1.210 1.180 1.200 632,500 1.1934
17 Jun 2020 1.220 1.260 1.190 1.200 592,500 1.2032
16 Jun 2020 1.220 1.220 1.200 1.220 55,000 1.2091
15 Jun 2020 1.250 1.250 1.190 1.200 565,000 1.2017
12 Jun 2020 1.250 1.250 1.180 1.230 100,000 1.2308
11 Jun 2020 1.270 1.270 1.190 1.220 302,500 1.2178
10 Jun 2020 1.220 1.230 1.190 1.230 272,500 1.2156
09 Jun 2020 1.250 1.270 1.180 1.210 257,500 1.2087
08 Jun 2020 1.180 1.210 1.150 1.200 745,000 1.1656
05 Jun 2020 1.180 1.190 1.150 1.150 385,000 1.1871
04 Jun 2020 1.140 1.180 1.130 1.180 405,000 1.1600
03 Jun 2020 1.190 1.190 1.100 1.100 1,447,500 1.1292
02 Jun 2020 1.180 1.180 1.130 1.180 605,000 1.1614
Summary
Current 2 Weeks
(18 Jun 2020 to 03 Jul 2020)
1.210 1.300 1.170 1.200 5,032,500 -
Previous 2 Weeks
(04 Jun 2020 to 17 Jun 2020)
1.140 1.300 1.130 1.200 3,680,000 -
4 Weeks from
(07 May 2020 to 03 Jun 2020)
1.230 1.300 1.170 1.100 12,247,500 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.